METTL14 and hepatocellular carcinoma: METTL14 can promote the maturation of miR-126, a tumour suppressor, by promoting the combination of pri-miR126 and DGCR8 modified with m6A. The lack of METTL14 in hepatocellular carcinoma can inhibit the production of miR126 and induce metastasis (18).